Spots Global Cancer Trial Database for Simultaneous Integrated Boost Preoperative Radiotherapy for Rectum Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Simultaneous Integrated Boost Preoperative Radiotherapy for Rectum Cancer
Official Title: Randomized Trial of Preoperative Radiotherapy With an Integrated Simultaneous Boost Compared to Chemoradiotherapy for T3-4 Rectal Cancer
Study ID: NCT01224392
Conditions
Study Description
Brief Summary: The investigators propose a randomized non-inferiority trial that compares preoperative Fluoro Uracil (FU)-based chemoradiotherapy to radiotherapy with a simultaneous integrated boost. In patients with T3-4 rectal cancer, the latter approach is considered preferential with regard to toxicity and cost. The metabolic response of the tumor, as assessed by 18F-2-Fluoro-2-Deoxyglucose-Positron Emission tomography (18F-FDG PET) or PET-CT, will be used as a surrogate marker of cause specific outcome
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
UZ Brussel , Vrije Universiteit Brussel, dienst Radiotherapie, Jette, Brussel, Belgium
UZ Brussel, Vrije Universiteit Brussel, dienst Radiotherapie, Jette, , Belgium
Contact Details
Name: Mark De Ridder, Prof.Dr.
Affiliation: UZ Brussel, Vrije Universiteit Brussel, dienst Radiotherapie
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
